Page last updated: 2024-10-29

imipramine and Demyelinating Diseases

imipramine has been researched along with Demyelinating Diseases in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.

Research Excerpts

ExcerptRelevanceReference
" We examined whether these behavioral and neurochemical changes observed in OBX mice were reversed by chronic administration of imipramine."1.62Disturbance of prefrontal cortical myelination in olfactory bulbectomized mice is associated with depressive-like behavior. ( Hong, L; Kurokawa, K; Miyagawa, K; Mochida-Saito, A; Takahashi, K; Takeda, H; Tsuji, M, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Takahashi, K1
Kurokawa, K1
Hong, L1
Miyagawa, K1
Mochida-Saito, A1
Takeda, H1
Tsuji, M1

Other Studies

1 other study available for imipramine and Demyelinating Diseases

ArticleYear
Disturbance of prefrontal cortical myelination in olfactory bulbectomized mice is associated with depressive-like behavior.
    Neurochemistry international, 2021, Volume: 148

    Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Cell Count; Demyelinating Diseases; Dep

2021